National Technical University of Athens (NTUA)
Βιοπληροφορική ανάλυση δεδομένων συστημικής βιολογίας για τη μοριακή μελέτη, χημειοπρόληψη και θεραπεία του ανθρώπινου ηπατοκυτταρικού καρκινώματος
Abstract
dc:descriptionHepatocellular carcinoma (HCC) - the most frequent subtype of liver cancer - is associated with high mortality due to its inherent heterogeneity, aggressiveness, and limited therapeutic regimes. HCC is a complex inflammation-related malignancy involving multiple genetic and epigenetic aberrations. The scope of this dissertation is the study and holistic investigation of underlying molecular mechanisms and characteristics of human HCC, as well as, the exploration of potential chemoprevention and/or therapeutic strategies, through systems biology and bioinformatics approaches. In this context, it has been previously shown by network analysis of proteomic data that the flavonoids epigallocatechin-3-gallate (EGCG) and fisetin (FIS) efficiently down-regulated pro-tumor cytokines released by HCC through inhibition of AKT/mTOR/RPS6 phospho-signaling. However, their mode of action at the global transcriptome level remains unclear. Therefore, the first part of this research endeavor attempts to compare gene expression alterations mediated by these compounds through a comprehensive transcriptome analysis based on RNA-sequencing (RNA-seq) in HEP3B, a responsive HCC cell line, upon perturbation with a mixture of prototypical stimuli mimicking conditions of tumor microenvironment, or under constitutive state. Analysis of RNA-seq data revealed extended changes on HEP3B transcriptome imposed by test nutraceuticals. Under stimulated conditions, EGCG and FIS significantly modified, compared to the corresponding control, the expression of 922 and 973 genes, respectively, the large majority of which (695 genes), was affected by both compounds. Hierarchical clustering based on the expression data of shared genes demonstrated an almost identical profile in nutraceutical-treated stimulated cells which was virtually opposite in cells exposed to stimuli alone. Downstream enrichment analyses of the co-modified genes uncovered significant associations with cancer-related transcription factors as well as terms of Gene Ontology (GO) and Reactome Pathways and highlighted extracellular matrix (ECM) dynamics as a nodal modulation point by nutraceuticals along with angiogenesis, inflammation, cell motility and growth. RNA-seq data for selected genes were independently confirmed by Real Time RT-qPCR. Overall, the present systems approach provides novel evidence, stepping up the mechanistic understanding of test nutraceuticals, thus rationalizing their clinical exploitation in new preventive/therapeutic modalities against HCC.In the second approach presented herein, 21 human HCC cell lines were analyzed to explore intertumor molecular diversity and pertinent drug sensitivity. An integrative computational approach based on exploratory and single-sample gene-set enrichment analysis of transcriptome and proteome data from the Cancer Cell Line Encyclopedia (CCLE) was implemented, followed by correlation analysis of drug-screening data from the Cancer Therapeutics Response Portal (CTRPv2) with curated gene-set enrichment scores. Acquired results classified HCC cell lines into two groups, a poorly and a well-differentiated group, displaying lower/higher enrichment scores in a “Specifically Upregulated in Liver” gene-set, respectively. Hierarchical clustering based on a published epithelial–mesenchymal transition (EMT) gene expression signature further supported this stratification. Between-group comparisons of gene and protein expression unveiled distinctive patterns, whereas downstream functional analysis significantly associated differentially expressed genes with crucial cancer-related biological processes/pathways and revealed concrete driver-gene signatures. Finally, correlation analysis highlighted a diverse effectiveness of specific drugs against poorly compared to well-differentiated HCC cell lines, possibly applicable in clinical research with patients with analogous characteristics. Overall, this study expanded the knowledge on the molecular profiles, differentiation status, and drug responsiveness of HCC cell lines, and proposes a cost-effective computational approach to precision anti-HCC therapies.
Degree
thesis:*- Grantor dc:publisher
- National Technical University of Athens (NTUA)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Agioutantis, Panagiotis
- Αγιουτάντης, Παναγιώτης
Subjects
dc:subject × 16- Βιοπληροφορική
- Ηπατοκυτταρικό καρκίνωμα
- Μεταγραφωμική
- Πρωτεωμική
- Φαρμακοτρόφιμα
- Συστημική βιολογία
- Bioinformatics
- Hepatocellular carcinoma
- Transcriptomics
- Proteomics
- Nutraceuticals
- Systems biology
- Επιστήμη Ηλεκτρονικών Υπολογιστών και Πληροφορική
- Φυσικές Επιστήμες
- Computer and Information Sciences
- Natural Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60447